IP Library › Granted Patent US 9,295,684
Granted Patent B2
US 9,295,684 · App. 13/912,679 · Granted Mar 29, 2016

Cream composition enhancing skin absorption of glucosamine

Inventor: Ming-Chen Lee (Taipei, TW)
A61K31/7008A61K9/0014A61K31/10A61K31/726A61K31/728A61K36/81A61K47/20A61K47/22A61K47/36A61K35/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,295,684
App. No.
13/912,679
Granted
Mar 29, 2016
Kind
B2
Abstract

The present invention relates to a cream composition of glucosamine, including at least 10 wt %-15 wt % of glucosamine HCL, a methylsulfonylmethane component, a chondroitin component, and a cream base, wherein the composition promotes penetration of glucosamine from skin of affected area by synergistic interaction between components, in order to enhance absorption of human body.

Claims (15)

1. A cream composition enhancing skin absorption of glucosamine, the cream composition comprising:

at least 10 wt %-15 wt % of glucosamine HCL, based on a total weight of the cream composition;

a methylsulfonylmethane component;

a chondroitin component; and

a cream base,

wherein the components forming the composition act synergistically to facilitate the glucosamine component to permeate into skin of affected body areas, thereby enhancing human absorption of glucosamine.

2. The cream composition of claim 1 , wherein the methylsulfonylmethane component is present in an amount of between 1 wt % and 5 wt %, and the chondroitin component is present in an amount of between 1 wt % and 5 wt %, both based on the total weight of the cream composition.

3. The cream composition of claim 1 , wherein the cream base further comprises a low-molecular-weight hyaluronic acid (HA) component.

4. The cream composition of claim 1 , wherein the low-molecular-weight hyaluronic acid (HA) component has a molecular weight of 5000-6000, and is present in an amount of between 0.1 wt % and 1 wt %, based on the total weight of the cream composition.

5. The cream composition of claim 1 , wherein the chondroitin component is made from shark cartilage.

6. The cream composition of claim 1 , wherein the cream base further comprises an Oligogeline component that is present in an amount of between 1 wt % and 10 wt %, based on the total weight of the cream composition.

7. The cream composition of claim 1 , wherein the cream base further comprises an absorption enhancing component that is present in an amount of between 1 wt % and 36 wt %, based on the total weight of the cream composition.

8. The cream composition of claim 7 , wherein the absorption enhancing component is dimethyl isosorbide (DMI).

9. The cream composition of claim 1 , wherein the cream base further comprises a blood circulation promoting component that is present in an amount of between 0.1 wt % and 1 wt %, based on the total weight of the cream composition.

10. The cream composition of claim 9 , wherein the blood circulation promoting component is menthol or capsicum frutescens .

Continuity (2)
Provisional Application 61656991 · Jun 7, 2012
Related Publication 20130330373A1 · Dec 12, 2013